Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1934617
Max Phase: Preclinical
Molecular Formula: C72H106N2O37S3
Molecular Weight: 1687.82
Molecule Type: Small molecule
Associated Items:
ID: ALA1934617
Max Phase: Preclinical
Molecular Formula: C72H106N2O37S3
Molecular Weight: 1687.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)c1cccc2c(S(=O)(=O)NCCSCCCCCS[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O[C@H]8O[C@H](CO)[C@@H](O[C@H]9O[C@H](COCc%10ccc%11ccccc%11c%10)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)cccc12
Standard InChI: InChI=1S/C72H106N2O37S3/c1-74(2)36-14-8-13-35-34(36)12-9-15-44(35)114(96,97)73-18-21-112-19-6-3-7-20-113-72-59(95)52(88)65(42(28-80)105-72)111-71-58(94)51(87)64(41(27-79)103-71)110-70-57(93)50(86)63(40(26-78)102-70)109-69-56(92)49(85)62(39(25-77)101-69)108-68-55(91)48(84)61(38(24-76)100-68)107-67-54(90)47(83)60(37(23-75)99-67)106-66-53(89)46(82)45(81)43(104-66)30-98-29-31-16-17-32-10-4-5-11-33(32)22-31/h4-5,8-17,22,37-43,45-73,75-95H,3,6-7,18-21,23-30H2,1-2H3/t37-,38-,39-,40-,41-,42-,43-,45-,46+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72+/m1/s1
Standard InChI Key: RVQILVPAHMDFFY-QIUTZOQLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1687.82 | Molecular Weight (Monoisotopic): 1686.5637 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Oka H, Koyama T, Hatano K, Matsuoka K.. (2012) Synthetic studies of bi-fluorescence-labeled maltooligosaccharides as substrates for α-amylase on the basis of fluorescence resonance energy transfer (FRET)., 20 (1): [PMID:22100259] [10.1016/j.bmc.2011.10.065] |
Source(1):